Literature DB >> 15297579

Inhibitory regulation of constitutive transient receptor potential-like cation channels in rabbit ear artery myocytes.

A P Albert1, W A Large.   

Abstract

In the present study we have investigated an inhibitory pathway regulating a constitutively active Ca(2+)-permeable non-selective cation conductance (I(cat)) in rabbit ear artery smooth muscle cells. Constitutive single channel activity of I(cat) was recorded in cell-attached and inside-out patches with similar unitary conductance values. In inside-out patches with relatively high constitutive activity the G-protein activator GTPgammaS inhibited channel activity which was reversed by the protein kinase C (PKC) inhibitor chelerythrine indicating a G-protein pathway inhibits channel activity via PKC. Spontaneous channel activity was also suppressed by the G-protein inhibitor GDPbetaS suggesting a G-protein is also involved in initiation of constitutive channel activity. Bath application of antibodies to G(alphaq)/G(alpha11) enhanced channel activity whereas anti-G(alpha1-3)/G(alphao) antibodies decreased basal channel activity which suggests that G(alphaq)/G(alpha11) and G(alphaiota)/G(alphao) proteins initiate, respectively, the inhibitory and excitatory cascades. The phospholipase C (PLC) inhibitor U73122 increased spontaneous activity which implies a role for PLC in the inhibitory pathway. Bath application of the diacylycerol (DAG) analogue 1-oeoyl-2-acetyl-sn-glycerol (OAG) decreased the probability of channel opening (NP(o)) and this was reversed by chelerythrine. Application of the PKC activator phorbol 12, 13-dibutyrate (PDBu) and chelerythrine, respectively, decreased and increased NP(o). These data indicate that spontaneously active cation channels are inhibited by a tonic inhibitory pathway involving G(alphaq)/G(alpha11)-mediated stimulation of PLC to generate DAG which activates PKC to inhibit channel opening. There were some patches with relatively low NP(o) and it was evident that the inhibitory pathway was particularly marked in these cases. Moreover in the latter patches GTPgammaS and OAG caused marked increases in NP(o). Together with inhibitory effects of GDPbetaS and anti-G(alpha1-3)/G(alphao) antibodies the results suggest that there is constitutive G(alphai)/G(alphao) protein activity leading to channel opening via a DAG-mediated but PKC-independent mechanism. Finally, with whole-cell recording it is shown that noradrenaline increases I(cat) and the noradrenaline-evoked response is markedly potentiated by PKC inhibition. This latter observation shows that PKC also limits agonist-evoked I(cat) in these arterial myocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15297579      PMCID: PMC1665202          DOI: 10.1113/jphysiol.2004.071738

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  10 in total

1.  Properties of a constitutively active Ca2+-permeable non-selective cation channel in rabbit ear artery myocytes.

Authors:  A P Albert; A S Piper; W A Large
Journal:  J Physiol       Date:  2003-04-04       Impact factor: 5.182

2.  M2 receptor activation of nonselective cation channels in smooth muscle cells: calcium and Gi/G(o) requirements.

Authors:  Y X Wang; B K Fleischmann; M I Kotlikoff
Journal:  Am J Physiol       Date:  1997-08

3.  Effects of G-protein-specific antibodies and G beta gamma subunits on the muscarinic receptor-operated cation current in guinea-pig ileal smooth muscle cells.

Authors:  H-D Yan; H Okamoto; T Unno; Ya D Tsytsyura; S A Prestwich; S Komori; A V Zholos; T B Bolton
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

4.  Comparison of spontaneous and noradrenaline-evoked non-selective cation channels in rabbit portal vein myocytes.

Authors:  A P Albert; W A Large
Journal:  J Physiol       Date:  2001-02-01       Impact factor: 5.182

Review 5.  Receptor-operated Ca2(+)-permeable nonselective cation channels in vascular smooth muscle: a physiologic perspective.

Authors:  William A Large
Journal:  J Cardiovasc Electrophysiol       Date:  2002-05

6.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

7.  Alpha 1-adrenoceptor activation of a non-selective cation current in rabbit portal vein by 1,2-diacyl-sn-glycerol.

Authors:  R M Helliwell; W A Large
Journal:  J Physiol       Date:  1997-03-01       Impact factor: 5.182

8.  The transient receptor potential protein homologue TRP6 is the essential component of vascular alpha(1)-adrenoceptor-activated Ca(2+)-permeable cation channel.

Authors:  R Inoue; T Okada; H Onoue; Y Hara; S Shimizu; S Naitoh; Y Ito; Y Mori
Journal:  Circ Res       Date:  2001-02-16       Impact factor: 17.367

9.  The effect of external divalent cations on spontaneous non-selective cation channel currents in rabbit portal vein myocytes.

Authors:  A P Albert; W A Large
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

10.  Regulation of canonical transient receptor potential (TRPC) channel function by diacylglycerol and protein kinase C.

Authors:  Kartik Venkatachalam; Fei Zheng; Donald L Gill
Journal:  J Biol Chem       Date:  2003-04-29       Impact factor: 5.157

  10 in total
  11 in total

1.  Pharmacological profile of phosphatidylinositol 3-kinases and related phosphatidylinositols mediating endothelin(A) receptor-operated native TRPC channels in rabbit coronary artery myocytes.

Authors:  J Shi; M Ju; W A Large; A P Albert
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

2.  Angiotensin II activates two cation conductances with distinct TRPC1 and TRPC6 channel properties in rabbit mesenteric artery myocytes.

Authors:  S N Saleh; A P Albert; C M Peppiatt; W A Large
Journal:  J Physiol       Date:  2006-09-14       Impact factor: 5.182

3.  TRPC3 properties of a native constitutively active Ca2+-permeable cation channel in rabbit ear artery myocytes.

Authors:  A P Albert; V Pucovsky; S A Prestwich; W A Large
Journal:  J Physiol       Date:  2006-01-05       Impact factor: 5.182

Review 4.  Transient receptor potential channels in the vasculature.

Authors:  Scott Earley; Joseph E Brayden
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

5.  Isoform-selective physical coupling of TRPC3 channels to IP3 receptors in smooth muscle cells regulates arterial contractility.

Authors:  Adebowale Adebiyi; Guiling Zhao; Damodaran Narayanan; Candice M Thomas-Gatewood; John P Bannister; Jonathan H Jaggar
Journal:  Circ Res       Date:  2010-04-08       Impact factor: 17.367

Review 6.  Signal transduction pathways and gating mechanisms of native TRP-like cation channels in vascular myocytes.

Authors:  A P Albert; W A Large
Journal:  J Physiol       Date:  2005-09-29       Impact factor: 5.182

7.  Role of phospholipase D and diacylglycerol in activating constitutive TRPC-like cation channels in rabbit ear artery myocytes.

Authors:  A P Albert; A S Piper; W A Large
Journal:  J Physiol       Date:  2005-05-26       Impact factor: 5.182

8.  Type 1 inositol 1,4,5-trisphosphate receptors mediate UTP-induced cation currents, Ca2+ signals, and vasoconstriction in cerebral arteries.

Authors:  Guiling Zhao; Adebowale Adebiyi; Eva Blaskova; Qi Xi; Jonathan H Jaggar
Journal:  Am J Physiol Cell Physiol       Date:  2008-09-17       Impact factor: 4.249

9.  Three distinct muscarinic signalling pathways for cationic channel activation in mouse gut smooth muscle cells.

Authors:  Takashi Sakamoto; Toshihiro Unno; Takio Kitazawa; Tetsuro Taneike; Masahisa Yamada; Jürgen Wess; Masakazu Nishimura; Seiichi Komori
Journal:  J Physiol       Date:  2007-04-26       Impact factor: 5.182

10.  Activation of native TRPC1/C5/C6 channels by endothelin-1 is mediated by both PIP3 and PIP2 in rabbit coronary artery myocytes.

Authors:  Sohag N Saleh; Anthony P Albert; William A Large
Journal:  J Physiol       Date:  2009-09-21       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.